We only have this paper's title and publication details.
Read it at the sourceExploratory study designs hybrid nanoparticles to enhance crizotinib delivery for lung cancer treatment, suggesting improved efficacy.
No takes yet. Share an insight, caveat, or question.
Rahangdale et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: